Another study demonstrated that low expression of miR-204 correlates to colon cancer pathogenesis, CRC progression, and drug resistance through overexpression of angiopoietin-like protein 2 (ANGPTL2). Here, ANGPTL2 is linked to malignant colon neoplasm.